心脏恶性淋巴瘤与扩散扩展到左心室
Daichi Terunuma1, Masanobu Miura1, Ko Teshima2
1Department of Cardiology, Iwate Prefectural Central Hospital, Japan.
Internal medicine (Tokyo, Japan)
|July 24, 2024
概括
恶性心脏淋巴瘤是一种罕见的疾病,可以扩散地影响左心室. 化疗改善了患有这种心脏淋巴瘤的患者的心脏功能,证明了治疗的有效性.
科学领域:
- 心脏病学 心脏病学
- 在瘤学瘤学.
- 病理学 病理学 病理学
背景情况:
- 恶性心脏淋巴瘤是一种不常见的诊断.
- 通常呈现为右侧心脏结节.
- 这一案例突出了非典型的扩散左心室干扰.
研究的目的:
- 报告一种罕见的恶性心脏淋巴瘤与扩散的左心室延伸的罕见病例.
- 描述这种疾病的诊断结果和治疗方法.
- 为了说明化疗对心脏功能改善的潜力.
主要方法:
- 患者介绍: 60多岁的女性呼吸不良和不适.
- 诊断成像:心声扫描显示左心室缩 (LVH);MRI显示扩散延迟对比度增强.
- 侵入性手术:心脏导管和心肌活检证实了由于心脏恶性淋巴瘤引起的心力衰竭.
主要成果:
- 诊断恶性心脏淋巴瘤与扩散的左心室透.
- 尽管有显著的左心室缩,但观察到轻微的透缩功能障碍.
- 用化疗成功治疗导致心脏功能得到改善和维持.
结论:
- 恶性心脏淋巴瘤可以表现为扩散的左心室参与,偏离典型表现.
- 多模式成像和活检对于诊断至关重要.
- 化疗可以有效地管理心脏淋巴瘤,导致功能恢复.
相关概念视频
Cardiac Catheterization III: Left Heart Catheterization
Left heart catheterization is an invasive diagnostic procedure used to evaluate the function and structure of the left side of the heart. It is generally performed to diagnose and treat cardiovascular conditions such as valve abnormalities, coronary artery disease, and congenital heart defects.Diagnostic and therapeutic purposesLeft heart catheterization serves various diagnostic and therapeutic purposes, including:Assessing coronary artery bypass grafts.Evaluating coronary artery disease in...
Mitral Stenosis II: Clinical features and Diagnostic Tests
Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy IV: Restrictive Cardiomyopathy
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...


